NASDAQ: IRON - Disc Medicine Opco Inc

Rentabilität für sechs Monate: +6.78%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Disc Medicine Opco Inc

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Disc Medicine Opco Inc

Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias, erythropoietic protoporphyria, and X-linked protoporphyria.

weitere details
In addition, the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown, Massachusetts.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

IPO date 2020-08-12
ISIN US2546041011
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.discmedicine.com
Цена ао 52.49
Preisänderung pro Tag: 0% (52.47)
Preisänderung pro Woche: +0.4403% (52.24)
Preisänderung pro Monat: -3.65% (54.46)
Preisänderung über 3 Monate: -18.17% (64.12)
Preisänderung über sechs Monate: +6.78% (49.14)
Preisänderung pro Jahr: -15.72% (62.26)
Preisänderung über 3 Jahre: +1 123.08% (4.29)
Preisänderung seit Jahresbeginn: -18.17% (64.12)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 4.27 4
P/E 0 0
EV/EBITDA -11.02 0
Gesamt: 2.25

Effizienz

Name Bedeutung Grad
ROA, % -25.29 0
ROE, % -27.73 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA -0.3296 10
Gesamt: 9.4

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 0 0
Rentabilität Ebitda, % 170.1 10
Rentabilität EPS, % -86.45 0
Gesamt: 6
Weitere Details

Institutionen Volumen Aktie, %
Atlas Venture Life Science Advisors, LLC 2745335 11.37
Orbimed Advisors LLC. 2269637 9.4
Bain Capital Life Sciences Investors, LLC 1332545 5.52
Adage Capital Partners GP L.L.C. 1308405 5.42
Paradigm Biocapital Advisors LP 1272279 5.27
Novo Holdings A/S 1090772 4.52
Perceptive Advisors LLC 895641 3.71
State Street Corporation 667301 2.76
Vanguard Group Inc 665452 2.76
Frazier Life Sciences Management, L.P. 655000 2.71

ETFAktie, %Rentabilität für das Jahr, %Dividenden, %
Virtus LifeSci Biotech Clinical Trials ETF 0.97272 63.04 0.33
iShares Micro-Cap ETF 0.2407 17.09 1.54048
Future Tech ETF 0.13875 426.34 0.8416
Principal Healthcare Innovators ETF 0.13875 618.5 0.8416
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.12922 18.2 1.66828
Invesco Nasdaq Biotechnology ETF 0.11589 28.58 0.8565
Direxion Daily S&P Biotech Bull 3x Shares 0.09631 4067.92 0.25924
Nuveen ESG Small-Cap ETF 0.08602 13.91 1.41019
ProShares Ultra Nasdaq Biotechnology 0.07817 51.7 0.85651
iShares ESG Aware MSCI USA Small-Cap ETF 0.0464 18.09 1.49366
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.03526 24.75 1.59225
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.02256 17.47 1.51433
ProShares UltraPro Russell2000 0.01709 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.01282 3 1.46057
iShares Morningstar Small-Cap ETF 0.01136 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01136 30.1 1.60498
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
iShares Russell 2000 Growth ETF 0.00769 38.04 0.6026
Avantis U.S Small Cap Equity ETF 0.00538 27.77 1.68271
ProShares Hedge Replication ETF 0.00471 5.92 1.47892
Humankind US Stock ETF 0.00322 18.81 1.99919
iShares Russell 3000 ETF 0.00174 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00156 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00026 30.98 1.40618
Dimensional U.S. Equity ETF 0.00013 31.53 1.3557
Avantis U.S. Equity ETF 0.00003 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.08220.631.28



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Donald William Nicholson Ph.D. Executive Chairman 164k 1958 (67 Jahre)
Dr. John D. Quisel Esq., J.D., Ph.D. CEO, President & Director 750.12k 1971 (54 Jahr)
Dr. William Jacob Savage M.D., Ph.D. Chief Medical Officer 687.74k 1974 (51 Jahr)
Dr. Brian MacDonald ChB, MB, Ph.D. Founder & Chair of Scientific Advisory Board 88.54k 1960 (65 Jahre)
Dr. Rahul Khara J.D., Pharm.D. General Counsel, Compliance Officer & Secretary N/A 1982 (43 Jahr)
Mr. Srikanth Venkatraman Ph.D. Senior VP & Head of Chemistry N/A
Ms. Hua Yang Ph.D. Senior Vice President & Head of Early Development and Clinical Pharmacology N/A
Ms. Jean M. Franchi Chief Financial Officer N/A 1966 (59 Jahre)
Mr. Jonathan Yu M.B.A. Chief Opearating Officer 539.32k 1981 (44 Jahr)
Ms. Pamela Stephenson M.P.H. Chief Commercial Officer N/A 1968 (57 Jahre)

Adresse: United States, Watertown. MA, 321 Arsenal Street - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.discmedicine.com